Rheumatoid disease and the heart: From epidemiology to echocardiography

Expert Opinion on Investigational Drugs

Volumn 14, Issue 1, 2005, Pages 65-76

  Bhatia, Gurbir S ^a   Sosin, Michael D ^a   Grindulis, Karl A ^b   Davis, Russell C ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Cardiovascular disease; Echocardiography; Mortality; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE;

ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY RISK; ECHOCARDIOGRAPHY; EPIDEMIOLOGICAL DATA; HEART DEATH; HEART FAILURE; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; JOINT DESTRUCTION; LIFE EXPECTANCY; MORTALITY; MYOCARDITIS; PERICARDIAL DISEASE; PREVALENCE; RHEUMATIC DISEASE; RHEUMATIC HEART DISEASE; RISK FACTOR; VALVULAR HEART DISEASE;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; ECHOCARDIOGRAPHY; HEART; HEART FAILURE, CONGESTIVE; HUMANS; PREVALENCE; RHEUMATIC HEART DISEASE;

EID: 12744275047     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.14.1.65     Document Type: Article

References (92)

1. COBB S, ANDERSON F, BAUER W: Length of life and cause of death in rheumatoid arthritis. N. Engl. J. Med. (1953) 249 553-556.
2. UDDIN J, KRAUS AS, KELLY HG: Survivorship and death in rheumatoid arthritis. Arthritis Rheum. (1970) 13:125-130.
3. MONSON RR, HALL AP: Mortality among arthritics. J. Chron. Dis. (1976) 29:459-467.
4. ALLEBACK P: Increased mortality in rheumatoid arthritis. Scand J. Rheumatol. (1982) 11:81-86.
5. PRIOR P, SYMMONS DP, SCOTT DL, BROWN R, HAWKINS CF: Cause of death in rheumatoid arthritis. Br. J. Rheumatol. (1984) 23 92-99.
6. SYMMONS DP, JONES MA, SCOTT DL, PRIOR P: Longterm mortality outcome in patients with rheumatoid arthritis; early presenters continue to do well. J. Rheumatol. (1998) 25:1072-1077.
7. MUTRU O, LAAKSO, M ISOMAKI H, KOOTA K: Ten year mortality and causes of death in patients with rheumatoid arthritis. Br. Med. J. (1985) 290:1797-1799.
8. JACOBSSON LT, KNOWLER WC, PILLEMEER S et al.: Rheumatoid arthritis and mortality: a longitudinal study in Pima Indians. Arthritis Rheum. (1993) 36:1045-1053.
9. MYLLYKANGAS-LUOSUJARVI R, AHO K, KAUTIAINEN H, ISOMAKI H: Cardiovascular mortality in women with rheumatoid arthritis. J. Rheumatol. (1995) 22:1065-1067.
10. WOLFE F, MITCHELL DM, SIBLEY JT et al.: The mortality of rheumatoid arthritis. Arthritis Rheum. (1994) 37:481-494.
11. WALLBERG-JONSSON S, OHMAN M-L, DAHLQVIST SR: Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J. Rheumatol. (1997) 24 445-451.
12. KVALVIK AG, JONES MA, SYMMONS DP: Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J. Rheumatol. (2000) 29:29-37.
13. BJORNADAL L, BAECKLUND E, YIN L, GRANATH F, KLARESKOG L, EKBOM A: Decreasing mortality in patients with rheumatoid arthritis: results from a large population-based cohort in Sweden, 1964-95. J. Rheumatol. (2002) 29:906-912.
14. LINDQVIST E, EBERHARDT K: Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann. Rheum. Dis. (1999) 58:11-14.
15. KROOT EJ, VAN LEEUWEN MA, VAN RIJSWIJK MH et al.: No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann. Rheum. Dis. (2000) 59 954-958.
16. PELTOMAA R, PAIMELA L, KAUTIAINEN H, LEIRISALO-REPO M: Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann. Rheum. Dis. (2002) 61:889-894.
17. GOODSON N, WILES NJ, LUNT M, BARRETT EM, SILMAN AJ, SYMMONS DP: Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum. (2002) 46:2010-2019.
18. LINDQVIST E, GEBOREK P, SAXNE T, EBERHARDT K: Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Arthritis Rheum. (2004) 50:959.
19. LEVY D, KENCHAIAH S, LARSON MG et al.: Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. (2002) 347:1397-1402.
20. CATHCART ES, SPODICK DH: Rheumatoid Heart Disease. N. Engl. J. Med. (1962) 266:959-964.
21. GABRIEL SE, CROWSON CS, O'FALLON WM: Comorbidity in arthritis. J. Rheumatol. (1999) 26:2475-2479.
22. WOLFE F, FREUNDLICH B, STRAUSS WL: Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J. Rheumatol. (2003) 30:36-40.
23. WOLFE F, MICHAUD K: Heart failure in rheumatoid arthritis: rates, predictors and the effect of anti-tumour necrosis factor therapy. Am. J. Med. (2004) 116:305-11.
24. McENTEGART A, CAPELL HA, CRERAN D, RUMLEY A, WOODWARD M, LOWE GD: Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (2001) 40 640-644.
25. BANKS MJ, FLINT EJ, BACON PA, KITAS GD: Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum. (2000) 43:S385.
26. SOLOMON DH, KARLSON EW, RIMM EB et al.: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 107:1303-1307.
27. TURESSON C, JARENROS A, JACOBBSSON L: Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community-based study. Ann. Rheum. Dis. (2004) 63 952-955.
28. DEL RINCON I, WILLIAMS K, STERN MP, FREMAN GL, ESCALANTE A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. (2001) 44:2737-2745.
29. ROSE GA: The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull. World Health Organ. (1967) 27:645-658.
30. TURESSON C, JACOBSSON L, BERGSTROM U: Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (1999) 38:668-674.
31. TURESSON C, O'FALLON M, CROWSON CS, GABRIEL SE, MATTESON EL: Occurrence of extra-articular disease is associated with excess mortality in a community-based cohort of patients with rheumatoid arthritis. J. Rheumatol. (2002) 29:62-67.
32. WALLBERG-JONSSON S, JOHANSSON H, OHMAN ML, RANTAPAA-DAHLQVIST S: Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive, rheumatoid arthritis: a retrospective cohort study from disease onset. J. Rheumatol. (1999) 26:2562-2571.
33. HELIOVAARA M, AHO Y, AROMAA A, KNEKT P, REUNANEN A: Smoking and risk of rheumatoid arthritis. J. Rheumatol. (1993) 20 1830-1835.
34. TURESSON C, O'FALLON WM, CROWSON CS, GABRIEL SE, MATTESON EL: Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann. Rheum. Dis. (2003) 62:722-727.
35. SVENSON KL, LITHELL H, HALLGREN R, SELINUS I, VESSBY B: Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I relativity to inflammatory activity. Arch. Intern. Med. (1987) 147:1912-1916.
36. RANTAPAA-DAHLQVIST S, WALLBERG-JONSSON S, DAHLEN G: Lipoprotein (a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann. Rheum. Dis. (1991) 50:366-368.
37. JOHNSON AG, NGUYEN TV, DAY RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann. Intern. Med. 121:289-300.
38. RIDKER PM, BURING JE, SHIH J, MATIAS M, HENNEKENS CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 98:731-733.
39. SATTAR N, McCAREY DW, CAPELL H, McINNESS IB: Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation (2003) 108:2957-2962.
40. VAN EDE AE, LAAN RFJM, BLOM HJ et al.: Homocysteine and folate status in metotrexate-treated patients in rheumatoid arthritis. Rheumatology (2002) 41:658-665.
41. BANKS MJ, PACE A, KITAS GD: Acute coronary syndromes present atypically and recur more frequently in rheumatoid arthritis than matched controls. Arthritis Rheum. (2001) 44:S53.
42. BANKS M, KITAS G: Patient's physical disability may influence doctors' perceptions of suitability for risk assessment (letter). Br. Med. J. (1999) 319:1266.
43. JOLLIFFE JA, REES K, TAYLOR RS, THOMPSON D, OLDRIDGE N, EBRAHIM S: Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst. Rev. (2001) 1: CD001800.
44. KOTHA P, McGREEVY MJ, KOTHA A. LOOK M, WEISMAN MH: Clin. Cardiol. (1998) 21:853-856.
45. LEBOWITZ WB: The heart in rheumatoid arthritis (rheumatoid disease). Ann. Intern. Med. (1963) 58:102-123.
46. BONFIGLIO T, ATWATER EC: Heart disease in patients with seropositive rheumatoid arthritis. Arch Int Med (1969) 124 714-719.
47. SOKOLOFF L: The heart in rheumatoid arthritis. Am. Heart J. (1953) 45:635-643.
48. LEVIN MH, KAPLAN L, MARCUS S: Heart in rheumatoid arthritis: a clinical-pathological correlation of 43 autopsied patients. Ann. Rheum. Dis. (1955) 14:430-431.
49. CRUICKSHANK B: Heart lesions in rheumatoid arthritis. J. Path. Bact. (1958) 76:223-240.
50. GOEHRS HR, BAGGENSTOSS AH, SLOCUMB CH: Cardiac lesions in rheumatoid arthritis. Arthritis Rheum. (1960) 3:298-308.
51. ESCALANTE A, KAUFMAN R, FRANCISCO PQUISIMORIO FP, BEARDMORE TD: Cardiac compression in rheumatoid arthritis. Semin. Arthritis Rheum. (1990) 20:148-163.
52. THOULD AK: Constrictive pericarditis in rheumatoid arthritis. Ann. Rheum. Dis. (1986) 45:89-94.
53. YURCHAK PM, DESHPANDE V: A 60-year old man with mild congestive heart fialure of uncertain cause. N. Engl. J. Med. (2003) 348:243-249.
54. ABU-SHAKRA M, NICOL P, UROWITZ MB: Accelerated nodulosis, pleural effusion, and pericardial tamponade during methotrexate therapy. J. Rheumatol. (1994) 21:934-937.
55. ABBAS A, BYRD BF: Right-sided heart fialure due to right ventricular cavity obliteration by rheumatoid nodules. Am. J. Cardiol. (2000) 86:711-712.
56. AHERN M, LEVER JV, COSH J: Complete heart block in rheumatoid arthritis. Ann. Rheum. Dis. (1983) 42:389-397.
57. SWEZEY RL: Myocardial infarction due to rheumatoid arteritis: an antemortem diagnosis. JAMA (1967) 199:855-857.
58. VAN ALBADA-KUIPERS GA, BRUIJN JA, WESTEDT ML, BREEDWELD FC, EULDERINK F: Coronary arteritis complicating rheumatoid arthritis. Ann. Rheum. Dis. (1986) 45:963-965.
59. PRAKASH R, ATASSI A, POSKE R, ROSEN KM: Prevalence of pericardial effusion and mitral valve involvemnt in patients with rheumatoid arthritis without cardiac symptoms: an echocardiographic evaluation. N. Engl. J. Med. (1973) 289:597-600.
60. NOMEIR AM, TURNER R, WATTS E, SMITH D, WEST G, EDMONDS J: Cardiac involvement in rheumatoid arthritis. Ann. Intern. Med. (1973) 79:800-806.
61. BACON PA, GIBSON DG: Cardiac involvement in rheumatoid arthritis: an echocardiographic study. Ann. Rheum. Dis. (1974) 33:20-24.
62. LAITINEN O, KENTALA E, LEIRISALO M: Electrocardiographic findings in patients with connective tissue disease. Scand J. Rheumatol. (1978) 7:193-198.
63. TLUSTOCHOWICZ W, PIOTROWICZ R, CWETSCH A, RACZKA A, KRAMARZ E, NOWAK J: 24-h ECG monitoring in patients with rheumatoid arthritis. Eur. Heart J. (1995) 16:848-851.
64. WISLOWSKA M, SYPAULA S, KOWALIK L: Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol. Int. (1999) 18 163-169.
65. GOLDELI O, DURSUN E, KOMSUOGLU B: Dispersion of ventricular repolarisation: a new marker of ventricular arrhythmias in patients with rheumatoid arthritis. J. Rheumatol. (1998) 25:447-450.
66. COWAN JC, YUSOFF K, MOORE M et al.: Importance of lead selection in QT interval measurement. Am. J. Cardiol. (1988) 61 83.
67. SOMBERG JC, MOLINAR J: Usefulness of QT dispersion as an electrocardiographically derived index. Am. J. Cardiol. (2002) 89:291-294.
68. CINDAS A, KUTSAL-GOKCE Y, TOKGOZOGLU L, KARANFIL A: QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand. J. Rheumatol. (2002) 31:22-26.
69. MALIK M, BATCHVAROW VN: Measurement, interpretation and clinical potential of QT dispersion. J. Am. Coll. Cardiol. (2000) 36:1749-1766.
70. McDONALD WJ, CRAWFORD MH, KLIPPEL JH: Echocardiographic assessment of cardiac structure and function in patients with rheumatoid arthritis. Am. J. Med. (1977) 63:890-896.
71. HERMANDEZ-LOPEZ E, CHAHINE RA, ANASTASSIADES P, RAIZNER AE, LIDSKY MD: Echocardiographic study of the cardiac involvement in rheumatoid arthritis. Chest (1977) 72:52-55.
72. DEL-REAL-MORE O, VILLAVICENCIO R, IGLESISAS-GAMARRA A et al.: Echocardiographic evaluation of patients with rheumatoid arthritis. Clin. Rheumatol. (1983) 2:381-385.
73. DAVIA JE, CHEITLIN MD, DE CASTRO CM: Absence of echocardiographic abnormalities of the anterior mitral valve leaflet in rheumatoid arthritis. Ann. Intern. Med. (1975) 83:500-502.
74. NOMEIR AM, TURNER RA, WATTS LE: Cardiac involvement in rheumatoid arthritis: follow-up study. Arthritis Rheum. (1979) 22:561-564.
75. MODY GM, STEVENS JE, MEYERS OL: The heart in rheumatoid arthritis-a clinical and echocardiographic study. QJM (1987) 65 921-928.
76. CORRAO S, SALLI L, ARNONE S et al.: Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease. Eur. Heart J. (1995) 16:253-256.
77. GUEDES C, BIANCHI-FIOR P, CORMIER B, BARTHELEMY B, RAT A-C, BOISSIER M-C: Cardiac manifestations of rheumatoid arthritis: a case-control trans-oesophageal study in 30 patients. Arthritis Res. (2001) 45:129-135.
78. TOUMANIDIS ST, PAPAMICHAEL CM, ANTONIADES LG et al.: Cardiac involvement in collagen diseases. Eur. Heart J. (1995) 16:257-262.
79. APPLETON CP HATLE LK, POPP RL: Relation of transmittal flow velocity patterns to left ventricular diastolic function: new insights from a combined haemodynamic and Doppler echocardiographic study. J. Am. Coll. Cardiol. (1988) 12:426-440.
80. ROWE IF, GIBSON DG, KEAT AC, BREWERTON DA: Echocardiographic diastolic abnormalities of the left ventricle in inflammatory joint disease. Ann. Rheum. Dis. (1991) 50:227-230.
81. MUSTONEN J, LAAKSO M, HIRVONEN T et al.: Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur. J. Clin. Invest. (1993) 23:246-253.
82. CORRAO S, SALLI L, ARNONE S, SCAGLIONE R, PINTO A, LICATA G: Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur. J. Clin. Invest. (1996) 26:293-297.
83. MONTECUCCO C, GOBBI G, PERLINI S et al.: Impaired diastolic function in active rheumatoid arthritis. Relationship with disease duration. Clin. Exp. Rheumatol. (1999) 17:407-412.
84. DI FRANCO M, PARADISO M, MAMNARELLA A et al.: Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation wit duration of disease. Ann. Rheum. Dis. (2000) 59:227-229.
85. ALPASLAN M, ONRAT E, EVCIC D: Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. Clin. Rheumatol. (2003) 22:84-88.
86. LEVENDOGLU F, UGURLU H: Ventricular function abnormalities in active rheumatoid arthritis; a Doppler echocardiographic study. Rhematol. Int. (2004) 24:141-146.
87. MAIONE S, VALENTINI G, GIUNTA A et al.: Cardiac involvement in rheumatoid arthritis; an echocardiographic study. Cardiology (1993) 83:234-239.
88. LANDEWE RB, VAN DEN BORNE BE, BREEDVELD FC, DIJKMANS BA: Methotrexate efficts in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet (2000) 355:1616-1617.
89. CHOI HK, HERNAN MA, SEEGER JD, ROBINS JM, WOLFE F: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 359:1173-1177.
90. McCAREY DW, McINNES IB, MADHOK R et al.: Trial of atorvastatin in rheumatoid arthritis (TARA): double blind, randomised placebo-controlled trial. Lancet (2004) 363:2015-2021.
91. ANKER SD, VON HAEHLING S: Inflammatory mediators in chronic heart failure. Heart (2004) 90:464-470.
92. ANKER SD, COATS AJ: How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int. J. Cardiol. (2002) 86:123-130.